Hasil Pencarian - Fritz Offner
Anda harus masuk terlebih dahulu
- Menampilkan 1 - 20 hasil dari 26
- Ke Halaman Berikutnya
-
1
Real-World Estimation of First- and Second-Line Treatments for Diffuse Large B-Cell Lymphoma Using Health Insurance Data: A Belgian Population-Based Study oleh Willem Daneels, Willem Daneels, Willem Daneels, Michael Rosskamp, Gilles Macq, Estabraq Ismael Saadoon, Anke De Geyndt, Fritz Offner, Fritz Offner, Fritz Offner, Hélène A. Poirel
Diterbitkan 2022-02-01Dapatkan teks lengkap
Artikel -
2
Circulating RNA biomarkers in diffuse large B-cell lymphoma: a systematic review oleh Philippe Decruyenaere, Fritz Offner, Jo Vandesompele
Diterbitkan 2021-02-01Dapatkan teks lengkap
Artikel -
3
-
4
-
5
Characterizing the Cell-Free Transcriptome in a Humanized Diffuse Large B-Cell Lymphoma Patient-Derived Tumor Xenograft Model for RNA-Based Liquid Biopsy in a Preclinical Setting oleh Philippe Decruyenaere, Willem Daneels, Annelien Morlion, Kimberly Verniers, Jasper Anckaert, Jan Tavernier, Fritz Offner, Jo Vandesompele
Diterbitkan 2024-09-01Dapatkan teks lengkap
Artikel -
6
-
7
Lipoprotein lipase SNPs rs13702 and rs301 correlate with clinical outcome in chronic lymphocytic leukemia patients. oleh Ans Rombout, Basile Stamatopoulos, Laurence Lagneaux, Sofie Lust, Fritz Offner, Evelien Naessens, Hanne Vanderstraeten, Bruno Verhasselt, Jan Philippé
Diterbitkan 2015-01-01Dapatkan teks lengkap
Artikel -
8
Quantitative Proteomics to Characterize Specific Histone H2A Proteolysis in Chronic Lymphocytic Leukemia and the Myeloid THP-1 Cell Line oleh Pieter Glibert, Liesbeth Vossaert, Katleen Van Steendam, Stijn Lambrecht, Filip Van Nieuwerburgh, Fritz Offner, Thomas Kipps, Maarten Dhaenens, Dieter Deforce
Diterbitkan 2014-05-01Dapatkan teks lengkap
Artikel -
9
P1116: HIGH COMPLETE METABOLIC RESPONSE RATES WITH EPCORITAMAB + R-CHOP IN PREVIOUSLY UNTREATED (1L) PATIENTS WITH HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA, INCLUDING DOUBLE/TRIPLE-... oleh Michael Roost Clausen, David Belada, Fritz Offner, Sven de Vos, Joshua Brody, Kim Linton, Sylvia Snauwaert, Raul Cordoba, Jun Wu, Irina Bykhovski, Liwei Wang, Ali Rana, Lorenzo Falchi
Diterbitkan 2023-08-01Dapatkan teks lengkap
Artikel -
10
High efficacy of huCD20-targeted AcTaferon in humanized patient derived xenograft models of aggressive B cell lymphoma oleh Willem Daneels, Alexander Van Parys, Leander Huyghe, Elke Rogge, Steffi De Rouck, Ruben Christiaen, Lennart Zabeau, Sylvie Taveirne, Jo Van Dorpe, Niko Kley, Anje Cauwels, Erik Depla, Jan Tavernier, Fritz Offner
Diterbitkan 2024-06-01Dapatkan teks lengkap
Artikel -
11
Predicting cytogenetic risk in multiple myeloma using conventional whole-body MRI, spinal dynamic contrast-enhanced MRI, and spinal diffusion-weighted imaging oleh Thomas Van Den Berghe, Bert Verberckmoes, Nicolas Kint, Steven Wallaert, Nicolas De Vos, Chloé Algoet, Maxim Behaeghe, Julie Dutoit, Nadine Van Roy, Philip Vlummens, Amélie Dendooven, Jo Van Dorpe, Fritz Offner, Koenraad Verstraete
Diterbitkan 2024-04-01Dapatkan teks lengkap
Artikel -
12
Safety and efficacy of abexinostat, a pan-histone deacetylase inhibitor, in non-Hodgkin lymphoma and chronic lymphocytic leukemia: results of a phase II study oleh Vincent Ribrag, Won Seog Kim, Reda Bouabdallah, Soon Thye Lim, Bertrand Coiffier, Arpad Illes, Bernard Lemieux, Martin J. S. Dyer, Fritz Offner, Zakia Felloussi, Ioana Kloos, Ying Luan, Remus Vezan, Thorsten Graef, Franck Morschhauser
Diterbitkan 2017-05-01Dapatkan teks lengkap
Artikel -
13
S194: TECLISTAMAB (TEC) + NIROGACESTAT (NIRO) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): THE PHASE 1B MAJESTEC-2 STUDY oleh Fritz Offner, Olivier Decaux, Cyrille Hulin, Sébastien Anguille, Anne Sophie Michallet, Luciano Costa, Cyrille Touzeau, Kevin Boyd, Deeksha Vishwamitra, Yue Guo, Zhuolu Niu, Julie Larsen, Lingling Chen, Arnob Banerjee, Jenna Goldberg, Jeffrey Matous
Diterbitkan 2023-08-01Dapatkan teks lengkap
Artikel -
14
Effectiveness and Safety of Ibrutinib for Chronic Lymphocytic Leukemia in Routine Clinical Practice: 3-Year Follow-up of the Belgian Ibrutinib Real-World Data (BiRD) Study oleh Ann Janssens, Zwi N. Berneman, Fritz Offner, Sylvia Snauwaert, Philippe Mineur, Gaetan Vanstraelen, Stef Meers, Isabelle Spoormans, Dominique Bron, Isabelle Vande Broek, Charlotte Van Bogaert, Birgit De Beleyr, Ann Smet, Lasse Nielsen, Robert Wapenaar, Marc André
Diterbitkan 2022-10-01Dapatkan teks lengkap
Artikel -
15
Exploring the cell-free total RNA transcriptome in diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma patients as biomarker source in blood plasma liquid biopsie... oleh Philippe Decruyenaere, Philippe Decruyenaere, Philippe Decruyenaere, Edoardo Giuili, Edoardo Giuili, Kimberly Verniers, Kimberly Verniers, Jasper Anckaert, Jasper Anckaert, Katrien De Grove, Malaïka Van der Linden, Dries Deeren, Jo Van Dorpe, Fritz Offner, Jo Vandesompele, Jo Vandesompele
Diterbitkan 2023-10-01Dapatkan teks lengkap
Artikel -
16
Inhibition of the Protein Arginine Methyltransferase PRMT5 in High-Risk Multiple Myeloma as a Novel Treatment Approach oleh Philip Vlummens, Philip Vlummens, Stefaan Verhulst, Kim De Veirman, Anke Maes, Eline Menu, Jérome Moreaux, Jérome Moreaux, Jérome Moreaux, Hugues De Boussac, Nicolas Robert, Elke De Bruyne, Dirk Hose, Fritz Offner, Karin Vanderkerken, Ken Maes, Ken Maes
Diterbitkan 2022-06-01Dapatkan teks lengkap
Artikel -
17
Shallow-depth sequencing of cell-free DNA for Hodgkin and diffuse large B-cell lymphoma (differential) diagnosis: a standardized approach with underappreciated potential oleh Lennart Raman, Malaïka Van der Linden, Ciel De Vriendt, Bliede Van den Broeck, Kristoff Muylle, Dries Deeren, Franceska Dedeurwaerdere, Sofie Verbeke, Amélie Dendooven, Katrien De Grove, Saskia Baert, Kathleen Claes, Björn Menten, Fritz Offner, Jo Van Dorpe
Diterbitkan 2020-12-01Dapatkan teks lengkap
Artikel -
18
Phase I Study of Safety and Pharmacokinetics of RO7297089, an Anti-BCMA/CD16a Bispecific Antibody, in Patients with Relapsed, Refractory Multiple Myeloma oleh Torben Plesner, Simon J. Harrison, Hang Quach, Cindy Lee, Adam Bryant, Annette Vangsted, Jane Estell, Michel Delforge, Fritz Offner, Patrick Twomey, Voleak Choeurng, Junyi Li, Robert Hendricks, Shannon M. Ruppert, Teiko Sumiyoshi, Karen Miller, Eunpi Cho, Fredrik Schjesvold
Diterbitkan 2023-01-01Dapatkan teks lengkap
Artikel -
19
Sustained efficacy and detailed clinical follow-up of first-line ibrutinib treatment in older patients with chronic lymphocytic leukemia: extended phase 3 results from RESONATE-2 oleh Paul M. Barr, Tadeusz Robak, Carolyn Owen, Alessandra Tedeschi, Osnat Bairey, Nancy L. Bartlett, Jan A. Burger, Peter Hillmen, Steven Coutre, Stephen Devereux, Sebastian Grosicki, Helen McCarthy, Jianyong Li, David Simpson, Fritz Offner, Carol Moreno, Cathy Zhou, Lori Styles, Danelle James, Thomas J. Kipps, Paolo Ghia
Diterbitkan 2018-09-01Dapatkan teks lengkap
Artikel -
20
The iR2 regimen (ibrutinib plus lenalidomide and rituximab) for relapsed/refractory DLBCL: a multicentre, non-randomised, open-label phase 2 studyResearch in context oleh Radhakrishnan Ramchandren, Peter Johnson, Nilanjan Ghosh, Jia Ruan, Kirit M. Ardeshna, Roderick Johnson, Gregor Verhoef, David Cunningham, Sven de Vos, Shireen Kassam, Luis Fayad, John Radford, Sarah Bailly, Fritz Offner, David Morgan, Javier Munoz, Jerry Ping, Edith Szafer-Glusman, Karl Eckert, Jutta K. Neuenburg, Andre Goy
Diterbitkan 2023-02-01Dapatkan teks lengkap
Artikel